Eight Cambridge academics are among 48 of the UK’s world leading researchers who have been elected to join the prestigious Fellowship of the Academy of Medical Sciences.
Artificial pancreas trial in young children with diabetes receives €4.6millon grant from European Commission05 Sep 2016
An international trial to test whether an artificial pancreas can help young children manage their type 1 diabetes will begin next year, thanks to a major grant awarded by the European Commission.
Technology assisting people with type 1 diabetes edges closer to perfection.
New research suggests it may be possible to predict an infant’s progress following surgery for congenital heart disease by analysing a number of important small molecules in the blood.
Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.
Screening could enable early intervention
A study of infant growth, tracking 2,400 babies from gestation to the age of two, has provided data of unique depth – and is already adding to our understanding of the development of life-threatening conditions, including obesity. The Cambridge University scientists who led the research now plan to follow the same children through another key phase of development - puberty.
A complex interplay of prenatal and postnatal factors determines the risk of childhood obesity and diabetes during later life.